MCL1 and acute myeloid leukemia: Indeed, constitutive FLT3 signaling upregulates the anti-apoptotic mediator MCL-1 [45]; siRNA-mediated MCL-1 inhibition restores the sensitivity of FLT3-ITD AML to therapy [45].